Investing.com UK - Financial Markets Worldwide
Open in App

FTSE 350 Pharmaceuticals & Biotechnology (FTNMX201030) Live

London
Currency in GBP
22,786.04
+144.90(+0.64%)
Delayed Data·
Advertisement

FTSE 350 Pharmaceuticals & Biotechnology (FTNMX201030) Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell

Technical Indicators

Sell

Moving Averages

Strong Sell

Summary:Strong Sell

Moving Averages:Strong SellBuy: (1)Sell: (11)
Technical Indicators:SellBuy: (4)Sell: (5)

Technical Indicators

Summary: SellBuy: 0Neutral: 3Sell: 5
Aug 17, 2026 12:37 GMT
Name
Value
Action
RSI(14)40.58Sell
STOCH(9,6)98.669Overbought
STOCHRSI(14)79.256Overbought
MACD(12,26)-112.74Sell
ADX(14)48.433Sell
Williams %R-1.616Overbought
CCI(14)43.6805Neutral
ATR(14)101.007Less Volatility
Highs/Lows(14)0Neutral
Ultimate Oscillator50.155Neutral
ROC-0.027Sell
Bull/Bear Power(13)-3.3485Sell

Moving Averages

Summary: Strong SellBuy: 1Sell: 11
Aug 17, 2026 12:37 GMT
Name
Simple
Exponential
MA5
22802.47
Sell
22778.07
Sell
MA10
22746.31
Buy
22789.57
Sell
MA20
22818.59
Sell
22854.67
Sell
MA50
23167.12
Sell
23077.41
Sell
MA100
23412.33
Sell
23419.83
Sell
MA200
24008.99
Sell
23957.03
Sell

Pivot Points

Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic22727.8322755.6722778.422806.2422828.9722856.8122879.54
Fibonacci22755.6722774.9922786.9222806.2422825.5622837.4922856.81
Camarilla22787.2322791.8722796.5122806.2422805.7822810.4122815.05
Woodie's22725.2922754.422775.8622804.9722826.4322855.5422877
DeMark's--22767.0422800.5622817.61--

FAQ

From a Technical Analysis Perspective, Is the FTSE 350 Pharmaceuticals & Biotechnology a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

What Are The Live Moving Averages for the FTSE 350 Pharmaceuticals & Biotechnology?

The moving averages for FTSE 350 Pharmaceuticals & Biotechnology show a Strong Sell outlook, considering moving averages ranging from MA5 to MA200, with 0 Buy signals and 12 Sell signals.

Is the FTSE 350 Pharmaceuticals & Biotechnology Overbought or Oversold?

The current Relative Strength Index (RSI) of FTSE 350 Pharmaceuticals & Biotechnology over the 14-day period is 40.580, which indicates the FTSE 350 Pharmaceuticals & Biotechnology index is currently a Sell

What Is the FTSE 350 Pharmaceuticals & Biotechnology's 14-Day RSI?

The current Relative Strength Index (RSI) of FTSE 350 Pharmaceuticals & Biotechnology over the 14-day period is 40.580.

What Is the FTSE 350 Pharmaceuticals & Biotechnology's Moving Average Convergence/Divergence (MACD)?

The FTSE 350 Pharmaceuticals & Biotechnology MACD is -112.740, which suggests that the index is a Sell.

What Is the FTSE 350 Pharmaceuticals & Biotechnology's 5-Day Moving Average?

The FTSE 350 Pharmaceuticals & Biotechnology 5-day moving average is 22802.47, suggesting that the index is a Sell.

What Is the FTSE 350 Pharmaceuticals & Biotechnology's 50-Day Moving Average?

The FTSE 350 Pharmaceuticals & Biotechnology 50-day moving average is 23167.12, suggesting that the index is a Sell.

What Is the FTSE 350 Pharmaceuticals & Biotechnology's 200-Day Moving Average?

The FTSE 350 Pharmaceuticals & Biotechnology 200-day moving average is 24008.99, suggesting that the index is a Sell.

What Is the Fibonacci Pivot Point Performance Value for the FTSE 350 Pharmaceuticals & Biotechnology?

The Fibonacci pivot point performance value for the FTSE 350 Pharmaceuticals & Biotechnology is 22806.24.
Install Our App
Follow us
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.